Intervention Protocol

Foscarnet for chronic hepatitis B

  1. Humberto Saconato1,*,
  2. G M Souza2,
  3. Álvaro N Atallah3,
  4. Eduardo R Parise4

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 23 JUL 2001

DOI: 10.1002/14651858.CD003616


How to Cite

Saconato H, Souza GM, Atallah ÁN, Parise ER. Foscarnet for chronic hepatitis B (Protocol). Cochrane Database of Systematic Reviews 2001, Issue 3. Art. No.: CD003616. DOI: 10.1002/14651858.CD003616.

Author Information

  1. 1

    Federal University of Rio Grande do norte, Department of Medicine, São Paulo, Vila Clementino, Brazil

  2. 2

    Federal University of São Paulo, Sao Paulo, Brazil

  3. 3

    Universidade Federal de São Paulo / Escola Paulista de Medicina, Brazilian Cochrane Centre, São Paulo, SP, Brazil

  4. 4

    Federal University of São Paulo, Gastroenterology, São Paulo, Brazil

*Humberto Saconato, Department of Medicine, Federal University of Rio Grande do norte, Alameda jauaperi 1083, São Paulo, Vila Clementino, 04523-014, Brazil. hsaconato@uol.com.br. hsaconato@yahoo.com.br.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 JUL 2001

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the beneficial and harmful effects of foscarnet in the treatment of chronic hepatitis B in adults and children.